ライフサイエンスコーパス: multivitamin

1 entrations were lower in subjects who used a multivitamin.

2 .15 [0.93 to 1.43]) compared to the low-dose multivitamin.

3 er by supplementation with folic acid plus a multivitamin.

4 le evidence supporting the prescription of a multivitamin.

5 may be too well-nourished to benefit from a multivitamin.

6 (95% CI, 0.77 to 1.15) for patients who used multivitamins.

7 telomere length among women who did not take multivitamins.

8 actors, such as physical activity and use of multivitamins.

9 Ninety-one percent of participants consumed multivitamins.

10 upplements and 26% to 77% reported using any multivitamins.

11 ts not taking Centrum (Pfizer, New York, NY) multivitamins.

12 into 1) no current use and 2) current use of multivitamins.

13 roidal anti-inflammatory drugs, statins, and multivitamins.

14 progression than did those who received the multivitamin alone (P = 0.04).

15 Multivitamins alone and selenium supplementation alone w

16 and multivitamins (vitamins A, C, and D) or multivitamins alone for 3 months.

17 .0 [9.0] years in those receiving the active multivitamin and 64.0 [9.1] years in those receiving the

18 intake over the past year and 10-year use of multivitamin and individual vitamin D supplements on a b

19 Multivitamin and mineral supplements had no significant

20 presence or absence of benefits from use of multivitamin and mineral supplements to prevent cancer a

21 assigned to an oral, 28-component, high-dose multivitamin and multimineral mixture or placebo.

22 itive performance did not differ between the multivitamin and placebo groups on the secondary outcome

23 mean cognitive change over time between the multivitamin and placebo groups or in the mean level of

24 5% CI, 0.88-1.09; P=.76), colorectal cancer (multivitamin and placebo groups, 1.2 and 1.4 events, res

25 reduction in the incidence of total cancer (multivitamin and placebo groups, 17.0 and 18.3 events, r

26 difference in the risk of cancer mortality (multivitamin and placebo groups, 4.9 and 5.6 events, res

27 of a daily multivitamin on prostate cancer (multivitamin and placebo groups, 9.1 and 9.2 events, res

28 Multivitamin and vitamin E use were not associated with

29 All participants received a multivitamin and were randomly assigned to oral DHA (30

30 28 was positively related to use of prenatal multivitamins and dietary intake of vitamin E; concentra

31 ncy, dose) during the previous 10 years from multivitamins and individual supplements/mixtures.

32 Multivitamins and multiminerals are widely used in the U

33 High-dose oral multivitamins and multiminerals did not statistically si

34 entation with a single supplement containing multivitamins and selenium was safe and significantly re

35 Multivitamins and the enhanced mebendazole regimen had a

36 In cause-specific analyses, use of multivitamins and use of vitamin E were associated with

37 Other variables included energy, nutrients, multivitamins, and alcohol.

38 one therapy, alcohol use, physical activity, multivitamins, and calcium supplements, and negatively a

39 While high doses of multivitamins, antioxidants, or lutein and zeaxanthin ar

40 Whether high-dose multivitamins are effective for secondary prevention of

41 Multivitamins are the most commonly used supplement in t

42 Although multivitamins are used to prevent vitamin and mineral de

43 Although multivitamins are widely used, there are limited prospec

44 who recurred or died within 90 days of their multivitamin assessment.

45 Multivitamins at multiple and single doses of the RDA ha

46 study was to evaluate the effect of VA/BC or multivitamin (B complex, vitamin C, and vitamin E) suppl

47 l trial of supplementation with either daily multivitamins (B vitamins and vitamins C and E), seleniu

48 , placebo-controlled trial of a common daily multivitamin, began in 1997 with continued treatment and

49 Na, P and Zn) determination in multimineral/multivitamins by atomic emission spectrometry in a mediu

50 o-controlled trial testing multivitamin use (multivitamin [Centrum Silver] or placebo daily) among US

51 results for the effects of periconceptional multivitamins containing folic acid and of folic acid fo

52 65 years or older, long-term use of a daily multivitamin did not provide cognitive benefits.

53 lation of US male physicians, taking a daily multivitamin did not reduce major cardiovascular events,

54 For participants taking multivitamins during the study, the highest intake of di

55 or age, smoking, physical activity, alcohol, multivitamins, family history, diet quality, energy inta

56 After adjustment for confounders, including multivitamins, family history, high triglycerides at bas

57 entions: chlorine for water purification and multivitamins for micronutrient deficiencies.

58 assess the balance of benefits and harms of multivitamins for the prevention of cardiovascular disea

59 Multivitamin formulations with or without minerals are t

60 disease prevention is stronger than that for multivitamins, formulations that cry out for greater sta

61 supplements of either single or multiple RDA multivitamins from enrollment until 6 wk after delivery.

62 There were 138 child deaths in the multivitamin group and 124 deaths in the placebo group (

63 significant AMD, there were 152 cases in the multivitamin group and 129 cases in the placebo group (H

64 The rates of prematurity were 16.9% in the multivitamin group and 16.7% in the placebo group (relat

65 rth weight was 7.8% among the infants in the multivitamin group and 9.4% among those in the placebo g

66 There were 872 cataracts in the multivitamin group and 945 cataracts in the placebo grou

67 tational age (<10th percentile; 10.7% in the multivitamin group vs. 13.6% in the placebo group; relat

68 (P = 0.007) were significantly lower in the multivitamin group.

69 tiple RDA (3045 + or - 549 g) and single RDA multivitamins group (3052 + or - 534 g; P = 0.83).

70 Compared with placebo, men taking a daily multivitamin had a statistically significant reduction i

71 Further, a daily multivitamin had no effect on total MI (3.9 and 4.2 even

72 The multivitamin had no effects.

73 o, the children born to mothers who received multivitamins had a reduced risk of anemia.

74 ent with a high-dose folic acid, B6, and B12 multivitamin in kidney transplant recipients did not red

75 ge who consumed a folic acid (FA)-containing multivitamin in the era of FA fortification are lacking.

76 e first 2 y postpartum: multivitamin, VA/BC, multivitamin including VA/BC, or placebo.

77 odeficiency virus infection to receive daily multivitamins (including multiples of the recommended di

78 4 y at enrollment, with complete dietary and multivitamin information, 162 men and 104 women develope

79 age of 55-74 y and with complete dietary and multivitamin information, 691 developed breast cancer be

80 nterventions with modifiable factors such as multivitamin intake may reduce risk.

81 iated with offspring BP after confounding by multivitamin intake was accounted for, and no associatio

82 ion with vitamin C, lutein, zeaxanthin, or a multivitamin may help certain populations, but is unlike

83 The intake of periconceptional multivitamins may decrease the risk of preterm births (P

84 neral deficiency, there is a perception that multivitamins may prevent cardiovascular disease (CVD).

85 ed dietary supplements, 31% of subjects used multivitamin mineral (MVM) products exclusively, 4% of s

86 The increasing use of multivitamin-mineral dietary supplements in younger to o

87 A multivitamin-mineral supplement is one low-cost way to e

88 to better policy in the field of vitamin and multivitamin-mineral supplement use should occupy our at

89 Multivitamin/mineral products (MVMs) are the dietary sup

90 ers, counseling by experts in nutrition, and multivitamin/mineral supplement after ITx could be of be

91 Although multivitamin/mineral supplements are commonly used in th

92 Multivitamin-multimineral (MVM) supplements are widely u

93 ast month, and 35% reported regular use of a multivitamin-multimineral (MVMM) product.

94 Multivitamin-multimineral composition databases use labe

95 A multivitamin-multimineral supplement with a combination

96 Eligible trials investigated daily multivitamin-multimineral supplementation for >/=1 y.

97 Use of multivitamin-multimineral supplements is widespread and

98 Multivitamin-multimineral treatment had no effect on mor

99 Multivitamin-multimineral treatment has no effect on mor

100 Across all studies, no effect of multivitamin-multimineral treatment on all-cause mortali

101 We aimed to determine whether multivitamin-multimineral treatment, used for primary or

102 n of one or a combination of components in a multivitamin/multimineral may accelerate cancer progress

103 S adults use dietary supplements and 33% use multivitamin/multimineral supplements.

104 Although multivitamins, multiminerals, and similar terms (eg, mul

105 Thus, multivitamins-multiminerals refers to products with wide

106 omes included use of any supplements; use of multivitamins/multiminerals (MVMM; defined as a product

107 l porridge and a separate dose of an aqueous multivitamin (MV) supplement between meals (control grou

108 The minimum dosage of multivitamins necessary for optimal benefits is unknown.

109 Folic acid from multivitamins needs to be reduced by DHFR before it part

110 3 HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania.

111 , there was no significant effect of a daily multivitamin on major cardiovascular events (11.0 and 10

112 The effect of a daily multivitamin on major cardiovascular events did not diff

113 There was no significant effect of a daily multivitamin on prostate cancer (multivitamin and placeb

114 al studies are needed to clarify the role of multivitamins on CVD.

115 enrolled in a trial examining the effect of multivitamins on HIV disease progression.

116 Use of multivitamins only or multiple supplements in addition t

117 h National Birth Cohort (1997-2003) reported multivitamin or folate-only supplement use during a 12-w

118 formation is summarized for periconceptional multivitamin or folic acid intake, which may reduce the

119 were observed for breast-feeding or maternal multivitamin or folic acid supplement use.

120 STF reviewed the evidence on the efficacy of multivitamin or mineral supplements in the general adult

121 Multivitamin or placebo daily.

122 Daily multivitamin or placebo.

123 ndazole twice daily for 3 d or 90 d of daily multivitamins or both using a 2 x 2 factorial design.

124 posure during the periconceptional period to multivitamins or liver consumption would decrease cleft

125 tene, vitamin C, vitamin D plus calcium, and multivitamins or multi-ingredient supplements was either

126 Most commonly used DSs were multivitamins or multiminerals (37.5%), protein and amin

127 roups were as follows: lt 150 microg/d (low; multivitamins or no supplement), 150-999 microg/d (middl

128 Weak support exists for multivitamins or other vitamin supplements from observat

129 ation were asked whether they regularly used multivitamins or prenatal vitamins in the past 6 months.

130 ethylation was also seen with current use of multivitamins (OR, 0.57; 95% CI, 0.40-0.83).

131 E), preformed vitamin A and beta-carotene + multivitamins, or placebo.

132 higher than among women who did not receive multivitamins (P=0.07).

133 Women in the control group received multivitamin pills, and the intervention group received

134 cipants receiving the combined supplement of multivitamins plus selenium had a significantly lower ri

135 Multivitamins plus selenium in a single supplement, vs p

136 ins and vitamins C and E, selenium alone, or multivitamins plus selenium, compared with placebo.

137 Iron (7 mg/d as multivitamin preparation with ferrous sulfate) or placeb

138 reparation with ferrous sulfate) or placebo (multivitamin preparation without iron) was given from 1

139 nation of major, minor and trace elements in multivitamin preparations and dietary supplements and, b

140 Multivitamin preparations are the most common dietary su

141 ation for deficits that are not prevented by multivitamin preparations.

142 metry in the quality control of multimineral/multivitamin preparations.

143 Multivitamin products could be better formulated to redu

144 Treatment with the high-dose multivitamin reduced homocysteine but did not reduce the

145 Multivitamins should be considered for all pregnant wome

146 Diplotype analyses among nonusers of multivitamins showed that individuals who carry the MTHF

147 oroid organ cultures were treated with AREDS multivitamin solution (MVS) or ZnCl(2).

148 ancer at randomization, enrolled in a common multivitamin study that began in 1997 with treatment and

149 these results suggest that regular use of a multivitamin supplement in the periconceptional period m

150 he authors evaluated the association between multivitamin supplement use and breast cancer risk in a

151 e of cancer provided detailed information on multivitamin supplement use.

152 urham, NC) and examined risk modification by multivitamin supplement use.

153 e observed among study subjects who reported multivitamin supplement use.

154 istics and tested the effect modification of multivitamin supplement use.

155 rient adequacy from food only was higher for multivitamin supplement users (n = 21,056) than for nonu

156 orbidity from overall or major cancers among multivitamin supplement users.

157 Ps in DNMT3A were associated with risk among multivitamin supplement users: 3' untranslated region (U

158 ly stomach cancer, for participants taking a multivitamin supplement, but this was in a borderline-de

159 se (ALT) in patients receiving the high-dose multivitamin supplement.

160 Multivitamin supplementation (partial correlation r(p)=0

161 +MV group, daily zinc supplementation alone, multivitamin supplementation alone, and the combined Zn+

162 evere deficiencies are prevented by standard multivitamin supplementation and what parameters are inf

163 ntrolled trial of high-dose vs standard-dose multivitamin supplementation for 24 months in 3418 patie

164 ch provides further support for the value of multivitamin supplementation in HIV-infected adults.

165 e prevention trial of male physicians, daily multivitamin supplementation modestly but significantly

166 However, the influence of multivitamin supplementation on cancer recurrence and de

167 We examined the effect of multivitamin supplementation on hemoglobin concentration

168 Multivitamin supplementation provided during pregnancy a

169 Multivitamin supplementation reduced the incidence of lo

170 Compared with placebo, multivitamin supplementation resulted in a hemoglobin in

171 Short-term multivitamin supplementation should be considered in pat

172 Compared with standard-dose multivitamin supplementation, high-dose supplementation

173 ritional deficits occurred despite long-term multivitamin supplementation, including vitamins B1, B12

174 The results of most large-scale trials of multivitamin supplements (combinations of > or = 2 vitam

175 Multivitamin supplements at a single dose of the RDA may

176 men without chronic diseases reported use of multivitamin supplements at least weekly over the past y

177 We investigated the efficacy of multivitamin supplements at single compared with multipl

178 Findings may not apply to use of commercial multivitamin supplements by the general U.S. population.

179 In adults receiving HAART, use of high-dose multivitamin supplements compared with standard-dose mul

180 Approximately 20-30% of Americans consume multivitamin supplements daily, indicating high public i

181 amin supplements compared with standard-dose multivitamin supplements did not result in a decrease in

182 omen received prenatal iron, folic acid, and multivitamin supplements irrespective of experimental as

183 Multivitamin supplements may place a subgroup of women (

184 a small, borderline-significant benefit from multivitamin supplements on cancer in men only and no ef

185 Multivitamin supplements represent a major source of mic

186 -year average daily dose from individual and multivitamin supplements were the exposures of primary i

187 Among nonusers of multivitamin supplements, compared with wild-type carria

188 To clarify the effects of multivitamin supplements, several large randomized clini

189 Despite widespread use of multivitamin supplements, their effect on cognitive heal

190 Only one-third of patients were taking multivitamin supplements.

191 m food and supplements; or vitamin C or E or multivitamin supplements.

192 e to assuming a default nutrient profile for multivitamin supplements.

193 e for the templates and can detect them from multivitamin tablets, corn flakes, energy drinks, cerebr

194 110 stable kidney transplant recipients to a multivitamin that included either a high dose (n=2056) o

195 eted villages, 951 (74.3%) of 1280 available multivitamin tickets were redeemed compared with 940 (66

196 The human Na(+)/multivitamin transporter (hSMVT) has been suggested to t

197 Na(+)-coupled I(-) uptake by the human Na(+)/multivitamin transporter (hSMVT), a related protein isol

198 Three transporters, SMVT (sodium-dependent multivitamin transporter for biotin and pantothenate), S

199 anzanian adults initiating ART enrolled in a multivitamin trial was followed at monthly clinic visits

200 uble-blind, placebo-controlled trial testing multivitamin use (multivitamin [Centrum Silver] or place

201 Multivitamin use (odds ratio (OR) = 1.46, 95% CI: 1.09,

202 Multivitamin use also did not improve the rates of grade

203 vitamin B(6), vitamin B(12), methionine) and multivitamin use among 497 Hodgkin lymphoma patients and

204 data indicate no overall association between multivitamin use and breast cancer risk but suggest that

205 e, no long-term clinical trials have studied multivitamin use and cognitive decline in older persons.

206 wn inconsistent associations between regular multivitamin use and CVD, with no long-term clinical tri

207 se association was observed between baseline multivitamin use and major CVD events among women aged >

208 founders, no associations were found between multivitamin use and mortality from all causes (for user

209 Multivitamin use and nutrient intakes were assessed with

210 In contrast, there was no relation between multivitamin use and preeclampsia among overweight women

211 as used to estimate the relation between any multivitamin use and PTBs (<37 wk) or SGA births (birth

212 The association between periconceptional multivitamin use and PTBs varied according to prepregnan

213 ermine the relation between periconceptional multivitamin use and the risk of small-for-gestational-a

214 tamin D intake on CVD mortality, and between multivitamin use and vitamin B12 intake on CVD mortality

215 nt interaction effects were observed between multivitamin use and vitamin B6 intake on myocardial inf

216 B6 intake on myocardial infarction, between multivitamin use and vitamin D intake on CVD mortality,

217 Diet and multivitamin use are unlikely to consistently prevent de

218 Multivitamin use attenuated the increased risk of breast

219 In multivariable analyses, multivitamin use compared with no use was not associated

220 Similarly, multivitamin use during adjuvant chemotherapy was not si

221 Among 1,038 patients, 518 (49.9%) reported multivitamin use during adjuvant chemotherapy.

222 Patients reported on multivitamin use during and 6 months after adjuvant chem

223 Multivitamin use during and after adjuvant chemotherapy

224 When updating information on multivitamin use during the course of follow-up, no asso

225 Current multivitamin use for > or =20 years or > or =6 times/wee

226 thers received antiretroviral (ARV) therapy, multivitamin use had no effect on mortality but was asso

227 Long-term multivitamin use had no effect on risk of cardiovascular

228 ii who answered an open-ended question about multivitamin use in 1999-2001 reported using 1246 differ

229 7-2001) reported at enrollment their regular multivitamin use in the past 6 months (n=1,823).

230 Regular preconception and postconception multivitamin use in women with a prepregnancy BMI (in kg

231 Recent epidemiologic findings suggest that multivitamin use increases the risk of mortality.

232 In this study, we evaluated whether diet and multivitamin use influenced the prevalence of gene promo

233 ovides the first epidemiologic evidence that multivitamin use is associated with longer telomere leng

234 The objective was to examine whether multivitamin use is associated with longer telomeres in

235 The objective was to investigate how multivitamin use is associated with the long- and short-

236 Multivitamin use is widespread in the United States, esp

237 The timing and frequency of periconceptional multivitamin use may be related to the risk of preeclamp

238 use and breast cancer risk but suggest that multivitamin use might reduce risk for women consuming a

239 ale physicians indicate that long-term daily multivitamin use modestly and significantly decreased th

240 dest suggestive inverse association (current multivitamin use of >/=6 times per week vs nonuse multiv

241 rsons who had a 10-year average frequency of multivitamin use of 6-7 days per week with nonusers was

242 line nutritional biomarkers on the effect of multivitamin use on CVD and other outcomes.

243 or baseline supplement use on the effect of multivitamin use on CVD end points.

244 influence the effect of randomized long-term multivitamin use on major CVD events.

245 There was no effect of multivitamin use on risk of preterm births (34-<37 weeks

246 dependent effect of regular periconceptional multivitamin use on the risk of preeclampsia.

247 Multivitamin use reported 6 months after completion of a

248 Greater frequency of multivitamin use showed a modest suggestive inverse asso

249 the timing and frequency of periconceptional multivitamin use to SGA births and PTBs and its clinical

250 Regular periconceptional multivitamin use was associated with a reduced risk of p

251 age, and household density, periconceptional multivitamin use was associated with a reduced risk of p

252 Daily multivitamin use was associated with a reduction in tota

253 her potential confounders were adjusted for, multivitamin use was associated with longer telomeres.

254 Regular periconceptional multivitamin use was associated with reduced risk of SGA

255 There also was no evidence indicating that multivitamin use was associated with risk of cancer, ove

256 rly women, neither baseline nor time-varying multivitamin use was associated with the long-term risk

257 Multivitamin use was nonsignificantly associated with a

258 Multivitamin use was nonsignificantly inversely associat

259 Multivitamin use was not related to total mortality.

260 Multivitamin use was not significantly associated with o

261 c acid, vitamin C, vitamin D, vitamin E, and multivitamin use were in the same range.

262 To assess the relation of multivitamin use with mortality and cancer, the authors

263 provided evidence regarding associations of multivitamin use with total and site-specific cancer inc

264 cal activity, vitamin D intake, fish intake, multivitamin use, and calcium supplement use.

265 Results did not vary by alcohol intake, multivitamin use, menopausal status, or oral contracepti

266 smoking (never compared with ever smokers), multivitamin use, season of BMD measurement (for cross-s

267 nd CVD, with no long-term clinical trials of multivitamin use.

268 18,551 women (65%) reported periconceptional multivitamin use.

269 longer telomeres, even after adjustment for multivitamin use.

270 ion (P = 0.06) between the DHFR genotype and multivitamin use.

271 vely to dietary fat intake and negatively to multivitamin use.

272 for maternal race/ethnicity, education, and multivitamin use.

273 ssociated with greater breast cancer risk in multivitamin users (51.2% of the study population) with

274 end = 0.05; P for interaction = 0.01] and in multivitamin users (OR for highest compared with the low

275 e DNA was on average 5.1% longer among daily multivitamin users (P for trend = 0.002).

276 After confounder adjustment, lean multivitamin users had a 71% reduction in preeclampsia r

277 adjusted risk of an SGA birth was reduced in multivitamin users regardless of their prepregnancy BMI

278 ith a body mass index of 22 kg/m(2), regular multivitamin users with the same body mass index had a 2

279 who reported a high intake of vitamin E, in multivitamin users, and in smokers.

280 For multivitamin users, the prevalence of adequacy improved

281 ncy and throughout the first 2 y postpartum: multivitamin, VA/BC, multivitamin including VA/BC, or pl

282 reviously reported that supplementation with multivitamins (vitamin B complex, vitamin C, and vitamin

283 he authors evaluated how supplemental use of multivitamins, vitamin C, and vitamin E over a 10-year p

284 We assessed the effect of daily zinc, multivitamin (vitamins C, E, and B-complex), and zinc an

285 to receive 3 mg/kg/day of elemental iron and multivitamins (vitamins A, C, and D) or multivitamins al

286 ts of preformed vitamin A and beta-carotene, multivitamins (vitamins B, C, and E), preformed vitamin

287 .0 and 10.8 events per 1000 person-years for multivitamin vs placebo, respectively; hazard ratio [HR]

288 A daily multivitamin was also not significantly associated with

289 individual supplement sources, but not from multivitamins, was associated with a 30% to 40% increase

290 In analyses restricted to nonusers of multivitamins, we observe a modest inverse trend between

291 obin concentrations among women who received multivitamins were 0.33 g/dL higher than among women who

292 Dietary data and habitual use of multivitamins were assessed from a modified Block food-f

293 er, coffee, beer, liquor, total alcohol, and multivitamins were each correlated with at least one met

294 Multivitamins were systematically prescribed after GBP,

295 Taking a multivitamin with minerals postbariatric surgery is a st

296 mized, placebo-controlled clinical trials of multivitamins with cancer as the primary endpoint have b

297 ns and vitamins C and E), selenium alone, or multivitamins with selenium vs placebo in a factorial de

298 supplements of vitamins C and E and low-dose multivitamins with the risk of age-related cataract amon

299 (vitamins C, E, and B-complex), and zinc and multivitamin (Zn+MV) supplementation on growth in infant

300 ants were randomly assigned to receive zinc, multivitamins, Zn+MVs, or a placebo at 6 wk of age and w